Tonix Pharmaceuticals (TNXP) Stock Surges Following Insider Buying And Q1 Results - Tonix Pharmaceuticals (NASDAQ:TNXP)

Tonix Pharmaceuticals (TNXP) Stock Surges Following Insider Buying And Q1 Results - Tonix Pharmaceuticals (NASDAQ:TNXP)

Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) shares are trading higher by 13.2% to $26.14 on Friday, continuing a strong week with a 33.5% gain fueled by encouraging first-quarter developments. Investor sentiment was also boosted Thursday after CEO Seth Lederman disclosed the purchase of 4,000 shares of company stock for $86,200. What To Know: Tonix on Monday reported a first-quarter loss of $2.84 per share, beating analyst estimates of a $3…